Pharmacokinetics of nordiazepam in physical dependence and precipitated abstinence in dogs.
Previous studies suggested that the extensive accumulation of benzodiazepines is an important factor in the induction of physical dependence. The mechanistic basis for accumulation of nordiazepam (ND) and its metabolite, oxazepam (OX), have been examined in crossover studies in drug-naive and in ND-dependent dogs that exhibited a flumazenil-precipitated abstinence syndrome. ND and parent OX have similar pharmacokinetic profiles. Steady-state plasma levels of ND and OX cannot be predicted from single-dose pharmacokinetics. Reduced plasma clearance of ND and altered plasma protein binding were observed in dogs physically dependent upon ND. The benzodiazepine antagonist, flumazenil, significantly reduces steady-state plasma levels of total and free ND.
Wala
E P
EP
Department of Anesthesiology, University of Kentucky, Lexington 40536-0216.
Martin
W R
WR
Sloan
J W
JW
D000284:Administration, Oral; D000818:Animals; D001798:Blood Proteins / Q000378:metabolism; D003975:Diazepam / Q000493:pharmacokinetics / Q000494:pharmacology; D004285:Dogs; D005260:Female; D005442:Flumazenil / Q000494:pharmacology; D006868:Hydrolysis; D007275:Injections, Intravenous; D003708:Nordazepam / Q000493:pharmacokinetics* / Q000494:pharmacology; D010076:Oxazepam / Q000097:blood / Q000494:pharmacology; D011485:Protein Binding; D013375:Substance Withdrawal Syndrome / Q000378:metabolism*; D019966:Substance-Related Disorders / Q000378:metabolism*
D001798:Blood Proteins; D005442:Flumazenil; D003708:Nordazepam; D010076:Oxazepam; D003975:Diazepam